Company Filing History:
Years Active: 2015-2018
Title: Michele Yelmene: Innovator in Vaccine Development
Introduction
Michele Yelmene is an accomplished inventor based in Del Mar, California, known for his significant contributions to the field of vaccine development. With a focus on infectious diseases, Yelmene has been instrumental in advancing medical technology through his innovative vaccine formulations.
Latest Patents
Yelmene holds two patents, with his latest inventions centered around a recombinant subunit dengue virus vaccine. This groundbreaking vaccine provides a robust immunogenic composition designed for administration to human subjects. The vaccine comprises recombinantly produced monomeric and dimeric forms of truncated dengue virus envelope glycoproteins. These components are formulated alongside an adjuvant and a pharmaceutically acceptable carrier to induce balanced tetravalent immune responses. Notably, the DEN4 protein component is a dimeric form of DEN4, and the compositions are tailored for use in the general population, including immunosuppressed and immunocompromised individuals. Methods of inducing a protective immune response in human patients are also included in this innovative patent.
Career Highlights
Throughout his career, Michele Yelmene has worked at Merck Sharp & Dohme Corporation, a leading global healthcare company dedicated to improving health outcomes. His expertise in vaccine research and development has positioned him as a prominent figure in biomedical innovation.
Collaborations
Yelmene has collaborated with distinguished professionals in his field, including Beth-Ann Griswold Coller and Vidya B Pai, Jr. These collaborations underscore the importance of teamwork in the pursuit of scientific advancements and the development of effective vaccines.
Conclusion
Michele Yelmene's work in vaccine innovation, particularly in the creation of dengue virus vaccines, highlights his commitment to improving public health. His patents reflect a deep understanding of immunology and the need for accessible healthcare solutions. Through his efforts, Yelmene continues to shape the future of medical science and contribute to groundbreaking advancements in vaccine technology.